Worldwide Clinical Trial Hosts Cardiovascular-Focused Webinar

Don’t Miss Tales from the Trenches: The Unique Challenges of Cardiovascular Outcome Trials

Don’t Miss Tales from the Trenches: The Unique Challenges of Cardiovascular Outcome Trials

Join Us in Recognizing Heart Health Month with this Informative and Free Live Webinar Event

 

What:

Cardiovascular outcome trials (CVOTs) continue to be an expensive and complex aspect of drug development with numerous challenges including:

  • Delivering complex trial design
  • Managing stakeholder diversity
  • Ensuring patient enrollment & retention
  • Implementing innovative technology

During this complimentary webinar, cardiometabolic industry thought leaders will share the uncommon approach Worldwide’s medical, scientific and operational experts have taken to ensure a large CVOT, involving more than 10,000 patients across nearly 500 sites in 8 countries, stays the course.

Who:

This webinar will be facilitated by three Worldwide Clinical Trial experts:

  • Karen Hill, SVP, Global Therapeutic Leader, Cardiometabolic
  • Nancy Newark, Executive Director, Project Management, Cardiometabolic
  • Christine Koppenhaver, Program Data Manager

 

When:

Wednesday, February 28

11 a.m. – Noon EST

Register:

To register for the upcoming webinar, CLICK HERE.

   

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,600 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs – in the best possible way. From early phase and bioanalytical sciences through late phase and post-approval, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID) and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit Worldwide.com.

MORE ON THIS TOPIC